. Author manuscript; available in PMC: 2022 Jun 27.

Published in final edited form as: J Urol. 2019 Jul 26;202(6):1188–1198. doi: 10.1097/JU.0000000000000456

Table 3.

Followup biopsy outcomes after hemigland cryoablation by baseline PCa Grade Group and followup biopsy status

		% 3/5-Yr Followup Biopsy Survival Outcome^*
GG	No. Pts	GG 1–5 PCa-Free	Clinically Significant PCa-Free
Any at baseline:
All pts	160	79/58	89/70
Followup biopsy^†	104	70/47	85/63
1 at Baseline:
All pts	39	70/62	94/80
Followup biopsy^†	34	67/57	93/77
2 or Greater at baseline:
All pts	121	81/58	88/64
Followup biopsy^†	70	72/43	81/60

Considering any Grade Group (1–5) cancer on followup prostate biopsy.

^†

Considering only the patients who underwent followup prostate biopsy.